Retrospective Study on the Efficacy and Safety of Pyrotinib-Based Therapy for HER2-Positive Nonbreast Advanced Solid Tumors

Table 5

Treatment-related adverse events that occurred in at least 10% of patients.

AE	All grade, (%)	Grade ≥ 3, (%)
Diarrhea	21 (84)	3 (12)
Asthenia	17 (65)	2 (8)
Nausea	12 (48)	1 (4)
Mucositis	10 (40)	1 (4)
Vomiting	8 (32)	1 (4)
Hypertension	7 (28)	0
Rash	4 (16)	0
Hand-foot syndrome	4 (16)	0
Abdominal pain	3 (12)	0
Anemia	3 (12)	0
Leukopenia	3 (12)	0